Maspin subcellular expression in wild-type and mutant TP53 gastric cancers

doi:10.4251/wjgo.v12.i7.741

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6523)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-7) series, Tables (1-5) series.

Item

Count

PDF

316

WORD

150

HTML

2713

Figures (1-7)

250

Tables (1-5)

241

Sum=3670

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

391

Download

671

Sum=1062

Publishing Process of This Article

Item

Count

Browse

682

Download

1109

Sum=1791

Jul 15, 2020 (publication date) through May 9, 2024

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastrointest Oncol. Jul 15, 2020; 12(7): 741-755
Published online Jul 15, 2020. doi: 10.4251/wjgo.v12.i7.741

Full Size Figure Download Figure

Figure 7 In patients with gastric cancer, wild-type TP53 cases (W) have a longer survival time, compared with mutant TP53 carcinomas, especially in tumors diagnosed before the occurrence of lymph node metastases.

Citation: Gurzu S, Jung I, Sugimura H, Stefan-van Staden RI, Yamada H, Natsume H, Iwashita Y, Szodorai R, Szederjesi J. Maspin subcellular expression in wild-type and mutant TP53 gastric cancers. World J Gastrointest Oncol 2020; 12(7): 741-755
URL: https://www.wjgnet.com/1948-5204/full/v12/i7/741.htm
DOI: https://dx.doi.org/10.4251/wjgo.v12.i7.741